Intervention not reported
Adverse events: Acupuncture versus sham or placebo control · women with primary dysmenorrhoea
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in adverse events (total adverse events) (oestrogen tablets vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review
Adverse events · women with primary dysmenorrhoea
Combined OCP probably leads to higher adverse events compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women having gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women after gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women having gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women with uterine fibroids
SPRM showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · women with uterine fibroids
GnRHa treatment probably leads to higher adverse events compared with placebo or no pretreatment (preoperative outcomes) (moderate certainty).
1 finding from 1 review
Adverse events · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with menopausal symptoms
Black cohosh showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events (GI) · obese women with subfertility
It is very uncertain whether pharmacological intervention changes adverse events (GI) compared with no intervention or placebo (very low certainty).
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
Antifibrinolytics showed no clear difference in adverse events (any) compared with no treatment or placebo (low certainty).
1 finding from 1 review
Other adverse events · women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ Miscarriage · patients with male subfertility
It is very uncertain whether antioxidants changes adverse events ‐ Miscarriage compared with placebo or no treatment (very low certainty).
1 finding from 1 review